Dachille Douglas A.
SEC CIK 1652908 · EDGAR
BoughtSold
Most active insiders at BBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kumar Neil | CEO, Dir | — | $61.54M |
| 2 | Cook Jennifer E. | Dir | — | $21.92M |
| 3 | MCCORMICK FRANK | Dir | — | $13.31M |
| 4 | Lo Andrew | Dir | — | $6.32M |
| 5 | Ellis Andrea | Dir | — | $5.65M |
| 6 | Valantine Hannah | Dir | — | $4.37M |
| 7 | DANIELS RONALD J | Dir | — | $3.89M |
| 8 | Trimarchi Thomas | Pres, CFO | — | $3.03M |
| 9 | Scott Randal W. | Dir | — | $2.09M |
| 10 | Apuli Maricel | CAO | — | $621.7K |
| 11 | Dachille Douglas A. | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-24 18:05 | 2026-06-22 | BBIO | BridgeBio Pharma, Inc. | Dachille Douglas A. | Dir | A - Grant | $0.00 | +3,990 | 10.6K | +61% | $0 |
| 2026-05-21 17:04 | 2026-05-20 | EQH | Equitable Holdings, Inc. | Dachille Douglas A. | Dir | A - Grant | $42.05 | +4,400 | 7,793 | +130% | +$185.0K | |
| D | 2025-06-24 | 2025-06-20 | BBIO | BridgeBio Pharma, Inc. | Dachille Douglas A. | Dir | A - Grant | $0.00 | +6,589 | 6,589 | New | $0 |
| 2025-05-23 | 2025-05-21 | EQH | Equitable Holdings, Inc. | Dachille Douglas A. | Dir | A - Grant | $0.00 | +3,393 | 3,393 | New | $0 | |
| 2025-02-05 | 2025-02-03 | PNC | PNC Financial Services | Dachille Douglas A. | Dir | P - Purchase | $198.13 | +100 | 100 | New | +$19.8K | |
| I | 2022-03-16 | 2022-03-14 | BBIO | BridgeBio Pharma, Inc. | Dachille Douglas A. | Dir | P - Purchase | $8.19 | +10.0K | 20.0K | +100% | +$81.9K |
| MI | 2022-01-06 | 2022-01-04+ | BBIO | BridgeBio Pharma, Inc. | Dachille Douglas A. | Dir | P - Purchase | $16.36 | +10.0K | 10.0K | New | +$163.6K |
Purchase Sale Sale after option exercise All abbreviations